Birth Defects Prevention Month: Medications

Hale said it is important to tell your doctor medications you're taking early in pregnancy because most birth defect occur in the first trimester.
More than four million babies are born each year in the Untied States. On average, three percent of those births will result in a birth defect ranging from minor to serious.
New mothers often worry about the effects medications can have on unborn children. Through years of research, many medications that cause severe birth defects have been identified and are avoided during pregnancy.
Thomas W. Hale, R.Ph., Ph.D., executive director of the InfantRisk Center, said there are fewer than 30 medications that cause severe birth defects.
“Accutane, alcohol, thalidomide and others can produce quite horrific birth defects,” Hale said. “We know which medications those are and we shy away from them.”
Most birth defects occur in the first trimester, which makes it important for women to be honest with physicians about medications they are taking before trying to conceive. However, physicians have learned that key factors to healthy babies are healthy mothers.
“A healthy woman makes a healthy baby,” Hale said. “Over the years, we’ve decided it’s best to keep moms healthy and treat their syndromes appropriately. As long as mom is healthy, she is going to make a healthy baby and not be so worried about many of these medications.”
Hale used depression as an example. He said depressed mothers have a higher risk of complications during pregnancy and delivery, and doctors now suggest moms treat their depression while pregnant knowing the risk of the medications are less than the risk of untreated depression.
“We get calls when mothers who refuse to tell their doctors what medications they are taking,” Hale said. “It’s important that the physician knows everything they are taking so they can make decisions on whether or not those are safe for the mother and their fetus.”
The InfantRisk Center serves as a resource to pregnant and breastfeeding mothers who have questions about medications. The call center is based solely on evidence-based medicine and research and provides the most current and accurate information possible. The InfantRisk Center also provides information to many health care providers.
Anyone with questions can call the InfantRisk Center from 8 a.m. to 5 p.m., Monday through Friday at (806) 352-2519.
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Experts Receive Junior Investigator Research Grants through Texas Alzheimer’s Research and Care Consortium
Texas Tech University Health Sciences Center (TTUHSC) researchers Aric Logsdon, Ph.D., and Jonathan Singer, Ph.D., received Junior Investigator Research Grants from the Texas Alzheimer’s Research and Care Consortium (TARCC).
CPRIT Awards TTUHSC Researcher $1.4 Million Cancer Grant in Efforts to Expand Rural Clinical Trials
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $1.4 million grant to Erin Barr, M.D., a clinician of pediatric hematology/oncology and researcher in the School of Medicine at Texas TTUHSC. Barr’s research, “Enhancing access to pediatric oncology clinical trials in West Texas,” received funding under the Recruitment or Retention of Clinical Trialists Award.
Texas Tech University Health Sciences Center’s Klein Selected to Leadership Role by the Texas Pharmacy Association
The Texas Pharmacy Association announced (May 19) the appointment of Mary Klein, Pharm.D., as assistant vice president of Strategic Initiatives and Practice Innovation.
